RxSight Analysts Slash Their Forecasts After Q2 Results
Portfolio Pulse from Avi Kapoor
RxSight Inc (NASDAQ:RXST) reported strong Q2 sales, beating analyst estimates and raising its FY24 revenue forecast. Despite this, shares fell 2.4% as analysts lowered their price targets.
August 06, 2024 | 12:12 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RxSight reported strong Q2 sales, beating estimates and raising its FY24 revenue forecast. However, shares fell 2.4% as analysts lowered their price targets.
Despite strong Q2 sales and an increased FY24 revenue forecast, RxSight's shares fell 2.4% due to analysts lowering their price targets. This mixed news creates a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100